The pharmacotherapy of low back pain

Show simple item record

dc.contributor.author Greeff, O.B.W. (Oppel Bernhardt Wilhelm)
dc.date.accessioned 2016-08-05T10:07:07Z
dc.date.available 2016-08-05T10:07:07Z
dc.date.issued 2016
dc.description.abstract About 60-80% of patients visiting a pharmacy have at some stage in their lives suffered from low back pain. The annual incidence in adults aged 35-55 years in developed countries is up to 45%. The differential diagnosis is broad and includes muscular strain, primary spine disease like disc herniation or degenerative arthritis, systemic diseases like metastatic cancer and regional diseases like aortic aneurisms. In the majority of cases, a specific diagnosis cannot be made. Most patients will improve in 1-4 weeks and will only need treatment for the acute symptoms after the initial history and physical examination. If, however, the pain recurs or worsens, the patient must be thoroughly examined and a specific diagnosis can become a challenge. en_ZA
dc.description.department Pharmacology en_ZA
dc.description.librarian am2016 en_ZA
dc.description.uri http://www.sapj.co.za/index.php/sapj en_ZA
dc.identifier.citation Greeff, OBW 2016, 'The pharmacotherapy of low back pain', SA Pharmaceutical Journal, vol. 83, no. 5, pp. 18-22. en_ZA
dc.identifier.issn 1015-1362
dc.identifier.uri http://hdl.handle.net/2263/56227
dc.language.iso en en_ZA
dc.publisher MedPharm Publications en_ZA
dc.rights © Medpharm en_ZA
dc.subject Patients en_ZA
dc.subject Diagnosis en_ZA
dc.subject Low back pain en_ZA
dc.subject Acute symptoms en_ZA
dc.title The pharmacotherapy of low back pain en_ZA
dc.type Article en_ZA


Files in this item

This item appears in the following Collection(s)

Show simple item record